Literature DB >> 15541750

Effect of mitoguazone on polyamine oxidase activity in rat liver.

Maria Elena Ferioli1, Debora Berselli, Samuela Caimi.   

Abstract

Mitoguazone is a known inhibitor of polyamine biosynthesis through competitive inhibition of S-adenosylmethionine decarboxylase. A recent renewed interest in mitoguazone as an antineoplastic agent prompted us to investigate the effect of the drug on polyamine catabolism in rat liver, since the organ plays an important role in detoxification mechanisms. Thus, the purpose of this work was to evaluate the effect of in vivo mitoguazone administration on polyamine catabolic enzymes. In particular, our interest was directed to the changes in polyamine oxidase activity, since this enzyme has been recently confirmed to exert important functions that until now were underestimated. Mitoguazone administration induced hepatic polyamine oxidase activity starting at 4 h after administration, and the enzyme returned to basal levels 96 h after treatment. The changes in enzyme activity were accompanied by changes in putrescine concentrations, which increased starting at 4 h until 72 h after treatment. We also evaluated the activity of the newly identified spermine oxidase, which was not significantly changed by mitoguazone treatment. Therefore, we hypothesized that the enzyme involved in mitoguazone response of the liver is the polyamine oxidase, which acts on acetylated polyamines as substrate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541750     DOI: 10.1016/j.taap.2004.05.013

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  3 in total

1.  Polyamine-based small molecule epigenetic modulators.

Authors:  Shiv K Sharma; Stuart Hazeldine; Michael L Crowley; Allison Hanson; Ross Beattie; Sheeba Varghese; Thulani M D Senanayake; Aiko Hirata; Fusao Hirata; Yi Huang; Yu Wu; Nora Steinbergs; Tracey Murray-Stewart; Ian Bytheway; Robert A Casero; Patrick M Woster
Journal:  Medchemcomm       Date:  2011-11-26       Impact factor: 3.597

2.  (Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.

Authors:  Shiv K Sharma; Yu Wu; Nora Steinbergs; Michael L Crowley; Allison S Hanson; Robert A Casero; Patrick M Woster
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

Review 3.  Design of polyamine-based therapeutic agents: new targets and new directions.

Authors:  M D Thulani Senanayake; Hemali Amunugama; Tracey D Boncher; Robert A Casero; Patrick M Woster
Journal:  Essays Biochem       Date:  2009-11-04       Impact factor: 8.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.